{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:51Z","timestamp":1793325771438,"version":"4.5.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian Government Research Training Program"},{"name":"Scholarship and Research Entry Scholarship Royal Australasian College of Physicians"},{"name":"Australian NHMRC Leadership Investigator Grants","award":["GNT1172900"],"award-info":[{"award-number":["GNT1172900"]}]},{"name":"Australian NHMRC Leadership Investigator Grants","award":["GNT1173361"],"award-info":[{"award-number":["GNT1173361"]}]},{"name":"NHMRC Emerging Leadership Investigator Grant","award":["1172873"],"award-info":[{"award-number":["1172873"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and objectives<\/jats:title>\n                  <jats:p>Curing Mycoplasma genitalium is challenging in the context of rising antimicrobial resistance and limited therapeutic options. There is an urgent need for globally relevant and effective treatment options using readily available and affordable agents. From September 2021 to August 2024 at Melbourne Sexual Health Centre, we prospectively evaluated microbial cure and tolerability of oral minocycline 100\u2005mg combined with metronidazole 400\u2005mg (twice daily for 14 days) for individuals with macrolide-resistant M. genitalium in whom fluroquinolones had failed or were not advised.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Microbial cure was defined as a negative test of cure (TOC) using transcription-mediated amplification 14\u201390 days after completing the regimen. The proportion cured and 95% confidence intervals (CIs) were calculated. Data on side effects and adherence were collected at TOC visits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Microbial cure in patients receiving the combination regimen was 80.8% (95% CI: 71.9\u201387.8%). Cure in those who had received preceding doxycycline was 90.3% (n\u200a=\u200a28\/31, 95% CI: 74.2\u201398.0%) compared to 76.7% (n\u200a=\u200a56\/73, 95% CI: 65.4\u201385.8%) in those who had not, P\u200a=\u200a0.172. Central nervous system and gastrointestinal side effects were commonly reported.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Minocycline with metronidazole cured 80% of macrolide-resistant infections in this cohort. Cure may be enhanced by the use of doxycycline before the combination regimen but larger studies are needed. Given limited options for treating resistant M. genitalium infections, the combined minocycline and metronidazole regimen may represent a promising option where no alternative drugs are available, or quinolones are contraindicated. Clinicians should be aware of and discuss side effects with patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaf142","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:31:33Z","timestamp":1747906293000},"page":"1878-1884","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant <i>Mycoplasma genitalium<\/i>"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1754-4920","authenticated-orcid":false,"given":"Kay","family":"Htaik","sequence":"first","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka A","family":"Vodstrcil","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L","family":"Plummer","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G","family":"Matthews","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P F","family":"Chow","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K","family":"Fairley","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona S","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2025070104562782900_dkaf142-B1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025070104562782900_dkaf142-B2","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4764790","article-title":"Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis","author":"Chua","year":"2024","journal-title":"Lancet"},{"key":"2025070104562782900_dkaf142-B3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/cid\/ciab1058","article-title":"Combination therapy for Mycoplasma genitalium, and new insights into the utility of parC mutant detection to improve cure","volume":"75","author":"Vodstrcil","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025070104562782900_dkaf142-B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/ofid\/ofaa291","article-title":"Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance","volume":"7","author":"Doyle","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025070104562782900_dkaf142-B5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ofid\/ofad427","article-title":"Efficacy of minocycline for the treatment of Mycoplasma genitalium","volume":"10","author":"Clarke","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025070104562782900_dkaf142-B6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/ofid\/ofad590","article-title":"Efficacy of sitafloxacin for Mycoplasma genitalium in an era of increasing antimicrobial resistance","volume":"10","author":"Samra","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025070104562782900_dkaf142-B7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2402.170902","article-title":"Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection","volume":"24","author":"Read","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2025070104562782900_dkaf142-B8","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1128\/AAC.00724-09","article-title":"Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR","volume":"53","author":"Hamasuna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104562782900_dkaf142-B9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s12879-021-06910-1","article-title":"Evaluation of treatment with two weeks of doxycycline on macrolide-resistant strains of Mycoplasma genitalium: a retrospective observational study","volume":"21","author":"Gosse","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025070104562782900_dkaf142-B10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/cid\/ciaa101","article-title":"A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease","volume":"72","author":"Wiesenfeld","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025070104562782900_dkaf142-B11","doi-asserted-by":"publisher","first-page":"0000623","DOI":"10.1128\/aac.00006-23","article-title":"In vitro susceptibility and resistance of Mycoplasma genitalium to nitroimidazoles","volume":"67","author":"Wood","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104562782900_dkaf142-B12","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3201\/eid2608.191806","article-title":"Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium","volume":"26","author":"Durukan","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2025070104562782900_dkaf142-B13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025070104562782900_dkaf142-B14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/cid\/ciz1031","article-title":"Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability","volume":"71","author":"Durukan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025070104562782900_dkaf142-B15","doi-asserted-by":"publisher","first-page":"0027822","DOI":"10.1128\/aac.00278-22","article-title":"Parc variants in Mycoplasma genitalium: trends over time and association with moxifloxacin failure","volume":"66","author":"Murray","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104562782900_dkaf142-B16","volume-title":"Australian Medicines Handbook","year":"2020"},{"key":"2025070104562782900_dkaf142-B17","doi-asserted-by":"publisher","first-page":"e0190199","DOI":"10.1371\/journal.pone.0190199","article-title":"Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples\u2014a pilot study","volume":"13","author":"Plummer","year":"2018","journal-title":"PLoS ONE"},{"key":"2025070104562782900_dkaf142-B18","doi-asserted-by":"publisher","first-page":"e0232321","DOI":"10.1128\/mBio.02323-21","article-title":"A prospective, open-label pilot study of concurrent male partner treatment for bacterial vaginosis","volume":"12","author":"Plummer","year":"2021","journal-title":"mBio"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/7\/1878\/63282447\/dkaf142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/7\/1878\/63282447\/dkaf142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:56:35Z","timestamp":1751360195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/7\/1878\/8140472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,5,22]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf142","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,22]]}}}